public health, bioethics

In the introduction, editor Marcelo Gleiser establishes the need for dialogue across the science-humanities divide in academia.

If governments were to use SARS-CoV-2 antibody tests to manage who can re-enter the workplace, society must accept a sacrifice of privacy.

Two coauthors of a new study discuss their findings about nearly 170 facilities in the southwestern US selling unproven therapies—and what should be done about them.

Despite claims of preclinical success by a leading surgeon, doctors, scientists, and medical ethicists say the science is not ready.  

The team that oversaw the first use of mitochondrial replacement therapy that resulted in a live birth has published an account of the procedure.

An international committee says scientists should be allowed to modify human embryos as long as strict oversight criteria are met. 

Regulatory and compliance expectations for animal-based research are demanding, while public and political scrutiny of animal research is rising.

A working group including members of the Lacks family approves the first projects to use the HeLa genome.

A presidential bioethics commission lays out the framework for testing the anthrax vaccine in children.

A new report lays out the pitfalls of consumer genetics and suggested strategies for safeguarding DNA’s privacy.  

Scientists have sequenced the genome of an 18.5 week-old fetus using blood and saliva samples taken from the parents.

Meet some of the people featured in the January 2012 issue of The Scientist.

A controversial Boston University laboratory could open by the end of the month, but at a lower safety rating than originally planned.

The makers of Marlboro cigarettes are asking researchers at a Scottish university to disclose data on children’s thoughts on tobacco marketing.

A bioethics commission announces the completion of an investigation into unethical US government-led experiments with STDs in Guatemala in the 1940s.